ARTICLE | Distillery Therapeutics
Therapeutics: Nuclear receptor subfamily 2 group F member 2 (NR2F2; COUP-TFII)
October 8, 2015 7:00 AM UTC
In vitro and mouse studies suggest inhibiting NR2F2 in cardiomyocytes could help treat dilated cardiomyopathy. Levels of NR2F2 were higher in myocardial tissue from dilated cardiomyopathy patients tha...